Nonadherence (pill count) and treatment response
| . | n . | M, % . | SD, % . | P . |
|---|---|---|---|---|
| All patients | .005 | |||
| Optimal response | 124 | 7.3 | 19.3 | |
| Suboptimal response | 14 | 23.2 | 23.8 | |
| Patients treated with imatinib ≥ 12 mo | .012 | |||
| Complete cytogenetic response | 98 | 9.0 | 18.6 | |
| Incomplete cytogenetic response | 9 | 26.0 | 24.4 | |
| All patients | .004 | |||
| Complete cytogenetic response | 109 | 9.1 | 18.1 | |
| Incomplete cytogenetic response | 15 | 23.9 | 19.2 |
| . | n . | M, % . | SD, % . | P . |
|---|---|---|---|---|
| All patients | .005 | |||
| Optimal response | 124 | 7.3 | 19.3 | |
| Suboptimal response | 14 | 23.2 | 23.8 | |
| Patients treated with imatinib ≥ 12 mo | .012 | |||
| Complete cytogenetic response | 98 | 9.0 | 18.6 | |
| Incomplete cytogenetic response | 9 | 26.0 | 24.4 | |
| All patients | .004 | |||
| Complete cytogenetic response | 109 | 9.1 | 18.1 | |
| Incomplete cytogenetic response | 15 | 23.9 | 19.2 |
n indicates subsample sizes; M, mean; SD, standard deviation; and P, probability to test statistic comparing response groups.